Original Research
Published on 02 Apr 2025
Association between weekend warriors and MASLD—a cross-sectional study of the NHANES database 2017–2020
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1531437
Type at least 3 characters
197 articles
Original Research
Published on 02 Apr 2025
Plasma methylated HIST1H3G as a non-invasive biomarker for diagnostic modeling of hepatocellular carcinoma
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1571737
Case Report
Published on 01 Apr 2025
Case Report: Fish bone-induced duodenal perforation leading to bile duct stones and portal vein thrombosis
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1546707
Original Research
Accepted on 31 Mar 2025
Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of Hepatocellular carcinoma
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1571761
Original Research
Accepted on 31 Mar 2025
A Nomogram for Predicting Early Bacterial Infection after Liver Transplantation: A Retrospective Study
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1563235
Original Research
Published on 28 Mar 2025
Construction and evaluation of a diagnostic model for metabolic dysfunction-associated steatotic liver disease based on advanced glycation end products and their receptors
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1539708
- 236 views
Original Research
Published on 28 Mar 2025
Exploring the severity and risk factors of non-alcoholic fatty liver disease using the SAF scoring system
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1510679
- 161 views
Original Research
Accepted on 27 Mar 2025
Periodontal Diseases, Potential Mediators and Development of Liver Fat Content: a Community-Based Large Cohort
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1563459
Case Report
Accepted on 27 Mar 2025
Common Bile Duct Exploration with Choledochotomy and Primary Repair during Pregnancy: Case Report
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1559568
Original Research
Accepted on 27 Mar 2025
Bacteroides fragilis 839 ameliorates anti-tuberculosis drugs-induced liver injury by suppressing inflammation and regulating gut microbiota in mice
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1538528
Editorial
Published on 27 Mar 2025
Editorial: Lipid metabolism in metabolic dysfunction- associated steatotic liver disease
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1584932
- 201 views
Editorial
Published on 27 Mar 2025
Editorial: Advances in chemotherapy-resistant hepatocellular carcinoma, volume II
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1594854
- 159 views
Review
Published on 26 Mar 2025
Ferroptosis in NAFLD: insights and the therapeutic potential of exercise
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1462145
- 136 views
Clinical Trial
Published on 25 Mar 2025
Effectiveness and risks of dapagliflozin in treatment for metabolic dysfunction-associated steatotic liver disease with type 2 diabetes: a randomized controlled trial
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1542741
- 281 views
Original Research
Accepted on 24 Mar 2025
Diagnostic and Prognostic Biomarkers in Autoimmune Hepatitis-Associated Cirrhosis: Insights into TBil, CD38, IL-22,TSP-1, GAL-3, and Cyc-C
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1564107
Original Research
Accepted on 24 Mar 2025
The association of advanced lung cancer inflammation index with nonalcoholic fatty liver disease in NHANES 2017-2020
in Hepatobiliary Diseases
Frontiers in Medicine
doi 10.3389/fmed.2025.1516464